Am J Trop Med Hyg 91:7780 Osorio L, Carter N, Arthur P, Bancone G, Gopalan S, Gupta SK et al (2015) Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P
Injectable Administration Intramuscular (IM): 200600mg per injection, 13 times weekly
Recalls & Warnings October 08, 2015 FDA Warns Seller of Omega-3 "Concussion" Supplement for Drug Claims On October 1, 2015, the FDA issued a warning letter to MPH Nutrition, LLC, following a review of the company's website which found statements made about Re:Mind Recover, a supplement promoted for recovery from concussions, to be drug claims which are not permitted for supplements
In extreme cases, complications can lead to Stevens-Johnson syndrome or kidney failure
As of now, orders are expected to ship by the end of July , though this estimate may change depending on supplier availability and demand